Latest / Markets & Money News Today | 2 Min News | THE DAILY NOW!
Windward Bio Files to Go Public on Nasdaq | Markets & Money News
Windward Bio Group, a Swiss biotech firm, has filed for an IPO in the U.S. to raise funds for clinical trials targeting respiratory and inflammatory diseases. With plans to list on Nasdaq under the ticker WWB, the company focuses on innovative antibody-based treatments, including a monoclonal antibody in advanced trials for severe asthma and a bispecific antibody for skin conditions like eczema. Despite a reported net loss of $42.6 million in early 2026 and no revenue yet, Windward has raised
www.TheDailyNewsNow.com
This is an automated, high-level news summary based on public reporting and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.